Srinivasa Reddy

UCLA Interdepartmental Program in Molecular Toxicology, Molecular Biology Institute

405 Hilgard Avenue

Box 951361

Los Angeles, CA 90095

United States

SCHOLARLY PAPERS

1

DOWNLOADS

83

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Are Aspirin and Apixaban Sufficient to Prevent Immunothrombosis in COVID-19?

Number of pages: 20 Posted: 29 Dec 2020
Kate Chiang, Srinivasa Reddy and Ajay Gupta
KARE Biosciences, UCLA Interdepartmental Program in Molecular Toxicology, Molecular Biology Institute and University of California Irvine
Downloads 83 (374,421)

Abstract:

Loading...

COX-2, SARS-CoV-2, COVID-19, Thromboinflammation, Immunothrombosis, Immunomodulatory, Ramatroban, Thromboxane A2, PGD2, Sepsis, DIC, anti-thrombotic, Aspirin, Heparin, Bronchoalveolar Lavage Fluid, pneumonia, ARDS